AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 152 filers reported holding AKERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,903,900 | -27.9% | 176,036 | -33.4% | 0.00% | -25.0% |
| Q2 2023 | $12,346,050 | +432.2% | 264,426 | +336.1% | 0.00% | +300.0% |
| Q1 2023 | $2,319,933 | +24.0% | 60,636 | +77.6% | 0.00% | 0.0% |
| Q4 2022 | $1,870,872 | +595.5% | 34,140 | +331.9% | 0.00% | – |
| Q3 2022 | $269,000 | +163.7% | 7,904 | -27.0% | 0.00% | – |
| Q2 2022 | $102,000 | -85.5% | 10,830 | -78.2% | 0.00% | – |
| Q1 2022 | $704,000 | -49.1% | 49,652 | -24.1% | 0.00% | – |
| Q4 2021 | $1,384,000 | +3.1% | 65,429 | +9.0% | 0.00% | – |
| Q3 2021 | $1,343,000 | +521.8% | 60,033 | +591.6% | 0.00% | – |
| Q2 2021 | $216,000 | -61.8% | 8,680 | -55.5% | 0.00% | – |
| Q1 2021 | $566,000 | – | 19,484 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $179,296 | 57.03% |
| Redmile Group, LLC | 2,632,912 | $144,283,578 | 5.90% |
| Avidity Partners Management LP | 3,825,000 | $209,610,000 | 4.54% |
| COMMODORE CAPITAL LP | 537,076 | $29,432 | 4.44% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $32,564,955 | 3.92% |
| Paradigm Biocapital Advisors LP | 604,544 | $33,129,011 | 3.89% |
| Yiheng Capital Management, L.P. | 1,468,905 | $80,495,994 | 3.56% |
| Altium Capital Management LP | 125,000 | $6,850,000 | 3.48% |
| Tri Locum Partners LP | 128,851 | $7,061,000 | 2.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 172,100 | $9,431,080 | 2.70% |